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ABSTRACT
ObjectiveaaTo determine the benefits of motor training on the sequence effect (SE), an essential component of bradykinesia in 
Parkinson’s disease (PD). 
MethodsaaSeven patients with de novo PD participated in this study. The patients performed regular pentagon drawing tests 
and exercises during four visits. The first two visits occurred before the start of medication, and the last two visits occurred at least 
six months after the start of medication. We assessed the severity of bradykinesia and SE at each visit and compared the results 
before and after exercise in both the de novo and treatment conditions. 
ResultsaaIn the de novo condition, the severity of bradykinesia significantly improved after motor training (p = 0.018), but it 
did not resolve and only showed a trend of improvement after treatment (p = 0.068). The severity of the SE decreased significantly 
in the drug-naïve condition (p = 0.028) but not after medication (p = 0.273).
ConclusionaaOur study suggests that regular motor training may be beneficial for the SE in PD. 
Key WordsaaBradykinesia, de novo; Exercise; Motor training; Parkinson’s disease; Sequence effect.
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INTRODUCTION
The progressive reduction in the speed and amplitude of re-
petitive movements, which is called the sequence effect (SE), is 
a characteristic of Parkinson’s disease (PD).1 Festinating gait is 
a typical example of the SE. During walking, the step length of 
PD patients gradually decreases, and in turn, they take steps more 
quickly and may lean forward and eventually fall.2,3 The SE may 
also be associated with motor arrest, such as the freezing of gait.3,4
Although the SE is well known, its treatment is unclear. Le-
vodopa is a standard treatment for PD, but it is unclear whether 
levodopa is also beneficial for the SE.5 It is imperative to develop 
effective therapies for the SE because the SE can cause several 
problems related to activities of daily living.3,6 
Currently, exercise training has been reported to be beneficial 
in PD, and the combination of medication and exercise is used 
to treat PD.7 The aim of this study was to determine whether mo-
tor training can improve symptoms of the SE. 
MATERIALS & METHODS
Patients 
Seven patients with de novo PD participated in this study. PD 
was diagnosed according to the UK Brain Bank criteria.8 The 
Hoehn and Yahr stage, the Unified Parkinson’s Disease Rating 
Scale score, the score of the Korean version of the Mini-Mental 
State Examination, years of education, disease duration, the Beck 
Depression Inventory score, and the Fatigue Severity Scale score 
were evaluated. Handedness was assessed with the Edinburgh 
Handedness Inventory.9 Five patients were right-handed, and two 
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patients were ambidextrous.10 The more affected hand was de-
termined based on the clinical features.4 All patients provided 
written informed consent, and the study was approved by the 
Institutional Review Board of Dongtan Sacred Heart Hospital 
(IRB number: 2012-001).
Procedures
The patients were asked to visit the clinic four times for this 
study and perform the same experiment during each visit. The 
first two visits occurred before the start of anti-parkinsonian med-
ications, and the remaining two visits occurred at least six months 
after the start of medications (Supplementary Figure 1 in the on-
line-only Data Supplement). We planned a 2-day exercise proto-
col because in general, patients do not like to visit the clinic fre-
quently, so it was expected to be challenging to recruit patients 
if the protocol spanned more days.
We used a repetitive pentagon drawing test, which has been 
previously used, to measure the severity of bradykinesia and the 
SE.4 At each visit, the patients were first asked to perform the re-
petitive pentagon drawing test, which included drawing a penta-
gon ten times, with an interval of 30 seconds between each repe-
tition. Then, patients were asked to continuously draw a pentagon 
ten times without a rest period between repetitions (continuous 
drawing test). This continuous drawing test was performed twice: 
with and without a dual task. The second drawing test was per-
formed 30 seconds after the first drawing test. Then, a pentagon 
drawing exercise was performed. In the drawing exercise test, 
the patients were also requested to continuously draw a penta-
gon ten times without a rest period between repetitions. Then, 
the patients had to perform ten repetitions with a 30-second rest 
period between each repetition. After the training period, the 
patients rested their hands for one minute, and then, the con-
tinuous drawing test was performed two more times: with and 
without a dual task. Finally, patients performed a repetitive pen-
tagon drawing test (Supplementary Figure 2 in the online-only 
Data Supplement).
Repetitive pentagon drawing test
The repetitive pentagon drawing test used was similar to that 
used in our previous study. We used the same equipment, and 
the details of the protocol are described in an earlier study.4 In 
brief, the protocol was as follows. The participants were asked to 
trace a regular pentagon, for which each side was 17 cm, with 
an electronic pen. The vertices of the sides were marked with a 
circle of 0.5 cm in diameter. The time it took for the participant 
to trace each side was measured from the time the participant 
traced one vertex to when he or she traced the next vertex. A 
pause indicated an instance at which the pen deviated from the 
pentagon near a vertex by a distance of 1.5 cm from the vertex. 
The movement time for each side was defined as the tracing time 
excluding pauses. The severity of bradykinesia was measured as 
the mean value of the 10 tracing times, and the severity of the SE 
was measured as the progressive changes in the mean movement 
time from the 2nd to 5th segment, which were assessed by the 
slope of the linear regression. The time taken to draw the first 
segment was excluded from the SE analysis because there was 
a technical error in measuring the departure time and the pause 
around the first vertex. Pentagon drawing was recorded using a 
digitizing tablet (WACOM Intuos3 PTZ-1231W, A3 wide, 488× 
305 mm) with high spatial (0.05 mm) and temporal resolution 
(200 Hz sampling rate). The movement times were stored on a 
personal computer.
Dual task
In a dual task paradigm, participants perform two tasks simul-
taneously.11 The dual task used in this study was serial subtrac-
tion. Each participant was asked to verbally count backward by 
three from 500 during the continuous drawing test. If the par-
ticipant had difficulty performing the task, the test was modified 
to counting backward by one from 100. If he or she still had dif-
ficulty performing the task, the participant was asked to name as 
many animals as they could. 
We used the dual task paradigm to determine whether partici-
pants performed the exercise correctly. The dual task paradigm 
is known to interfere with motor performance, but after motor 
learning, the dual task effect decreases. Therefore, we thought that 
if participants performed the exercise as instructed after training, 
the time it took them to draw pentagons with the dual task would 
be shorter after the completion of the pentagon drawing exer-
cises. In addition, the dual task paradigm has been reported to 
increase attention and help people acquire new skills.12,13 The dual 
task cost (DTC) is used to calculate the dual task effect, and the 
equation is as follows:12
DTC = (Single task – Dual task) × 100. 
                                                 Single task            
Statistical analysis
The data are expressed as means ± SDs. The data were ana-
lyzed with the Wilcoxon signed-rank test. The severity of brady-
kinesia and the SE before exercise at the 1st visit and after exer-
cise at the 2nd visit were compared (drug-naïve condition), and 
the severity of bradykinesia and the SE before exercise at the 3rd 
visit and after exercise at the 4th visit were also examined (treat-
ment condition). We compared the difference in the DTC of the 
continuous drawing tests from before training at the 1st visit to 
after training at the 2nd visit. We used the single task data re-
corded before exercise at the 1st visit for these two DTC calcu-
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lations. Likewise, we also compared the difference in the DTC 
before practice at the 3rd visit to after practice at the 4th visit. Val-
ues of p < 0.05 were regarded as significant.
RESULTS
The patient characteristics are summarized in Table 1, and data 
for each individual are presented in Supplementary Table 1 (in 
the online-only Data Supplement). The right side was more af-
fected in five patients, and the left side was more affected in two 
patients. Seven patients attended the first two visits (i.e., before 
medication), but only four patients attended the last two visits 
(follow-up after medication: 10.5 ± 9 months). Before the start 
of medication, the severity of bradykinesia statistically signifi-
cantly improved after motor training (p = 0.018) (Figure 1A) but 
only showed a trend of improvement after the start of medication 
(p = 0.068) (Figure 1A). The severity of SE significantly improved 
before medication (p = 0.028) (Figure 1B) but did not improve 
after medication (p = 0.273) (Figure 1B). The DTC significantly 
increased after exercise at the 2nd visit before the start of medi-
cation (p = 0.018), but the magnitude of improvement did not 
reach statistical significance after exercise at the 4th visit after the 
start of medication (p = 0.068) (Supplementary Table 2 in the 
online-only Data Supplement). We also analyzed the effects of 
medication on the SE, i.e., pre-exercise SE at the 1st visit and pre-
exercise SE at the 3rd visit, but we did not find an effect of med-
ication (p = 1.000) (Supplementary Table 3 in the online-only 
Data Supplement).
DISCUSSION
Our study demonstrated that motor training improved bra-
dykinesia and the SE before medication was started but failed to 
improve them after medication was started, which may be due 
to the small number of patients who attended follow-ups. 
It is well known that motor training can reduce bradykinesia. 
Various types of exercise and physical therapy have been report-
ed to be effective in treating motor and nonmotor symptoms in 
PD patients, even in the long term.7,14 To increase the benefits of 
physical activity in PD patients, it is essential to know not only 
which kinds of physical activities are most helpful to patients15 
but also which symptoms improve with physical activity. 
Table 1. Patient characteristics
Results (n = 7)
Age (years) 57.9 ± 11.8
Sex (men:women) 6:1
Disease duration (years) 0.7 ± 0.3
K-MMSE 27.7 ± 2.2
Education (years) 11.7 ± 5.5
H&Y stage 2.0 ± 0.0
UPDRS total 31.9 ± 6.9 
UPDRS I 1.3 ± 1.0
UPDRS II 6.4 ± 2.9
UPDRS III 24.1 ± 7.8
BDI 8.0 ± 5.1
FSS 2.8 ± 1.1
The values are means ± SDs. K-MMSE: the Korean version of the Mini-
Mental State Examination, H&Y stage: Hoehn and Yahr stage, UPDRS: 
Unified Parkinson’s Disease Rating Scale, BDI: Beck Depression Inven-
tory, FSS: Fatigue Severity Scale.
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Figure 1. Changes in the severity of bradykinesia (A) and the sequence effect (B) after exercise. The left column shows the changes before 
treatment, and the right column shows the changes after medication. The colored lines and numbers indicate individual patients. *p < 0.05 
indicates a significant difference. 
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We do not know the mechanism by which motor training im-
proves the SE, but we think that exercise-induced neuroplasticity 
may be one mechanism because it was reported that the SE is 
associated with the anterior cingulate cortex and the cerebellum.4 
Exercise-induced neuroplastic changes in several brain regions, 
including the cingulate and cerebellum, have been reported in 
PD patients.16 The changes in dopaminergic activity in the cau-
date caused by physical activity may be another mechanism,17 
considering that an association between caudate dopaminergic 
activity and the SE has been previously reported.4
Under medication, the symptoms of the SE did not improve 
after exercise, and there are possible explanations for this result. 
First, the number of patients who attended follow-ups was very 
small, and therefore, it is not easy to interpret the follow-up re-
sults. Second, it can be argued that because dopaminergic med-
ication already affected the SE, there was no improvement after 
exercise. However, we did not find any reductions in the severity 
of the SE after treatment in this study (Supplementary Table 3 
in the online-only Data Supplement), and as mentioned above, 
it is still unclear whether dopaminergic medication can improve 
symptoms of the SE.5 
Because several previous studies have shown that the repetitive 
pentagon drawing test can be used to detect the SE, we adopted 
this test for our research, and this digitized repetitive pentagon 
drawing test yielded reliable measurements of both the training 
and medication effects. These kinds of computerized, objective 
analyses, if validated, may be useful in future large-scale studies. 
Our study has some limitations. We conducted this research 
with a small number of participants. Additional research measur-
ing neuroplastic changes in more patients is needed. In addition, 
the delayed effect of exercise on the SE remains to be explored. 
Second, the 2-day exercise protocol might be too short to assess 
motor learning. Third, we used the pentagon drawing test be-
cause previous studies have shown that the pentagon drawing test 
is an excellent tool for measuring the SE,4,18,19 but it might not be 
a good tool to measure the effects of motor practice. Fourth, be-
cause the DTC did not improve after motor training in patients 
with medication, it might be possible that the participants did not 
practice the task properly. Nevertheless, the mean values of the 
DTC differed considerably between pre-exercise at visit 3 and 
postexercise at visit 4, but the difference was not statistically sig-
nificant, perhaps due to the small number of participants.
Supplementary Materials
The online-only Data Supplement is available with this article at https://
doi.org/10.14802/jmd.20045.
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Supplementary Figure 1. Flow chart of the schedule of visits. UPDRS: Unified Parkinson’s Disease Rating Scale, K-MMSE: Korean ver-
sion of the Mini-Mental State Examination, BDI: Beck Depression Inventory, FSS: Fatigue Severity Scale.
Bradykinesia 
Sequence effect
Pentagon drawing  
   without dual task  
(× 10)
Pentagon drawing  
  with dual task (× 10)
Pentagon drawing  
  with dual task (× 10)
Pentagon drawing  
   (× 10) × 10 blocks  
= total 100 times
Pentagon drawing  




Measurement MeasurementDual task Dual taskExercise
Supplementary Figure 2. Experimental procedure for each visit.


















III BDI FSS Medication
1 71 F 0.5 24 3 2 25 1 7 17 14 2.22
Levodopa/benserazide (100/25 mg) 1.5 tablet three times per day,  
  trihexyphenidyl 1 mg once per day
2 45 M 1.0 30 16 2 31 0 10 21 5 3.11
Ropinirole prolonged release 12 mg once per day,  
  amantadine 100 mg once per day
3 71 M 1.0 30 9 2 26 2 3 21 3 3.33
ropinirole prolonged release 12 mg once per day,  
  amantadine 100 mg twice per day
4 64 M 0.6 26 6 2 39 0 2 37 0 1.33
Levodopa/carbidopa (100/25 mg) 0.75 tablet three times per day,  
  trihexyphenidyl 1 mg once per day, rasagiline 1 mg once per day
5 38 M 0.4 28 12 2 28 3 9 16 14 4.11
6 54 M 0.5 30 18 2 45 1 9 35 11 4.11
7 62 M 1.0 26 18 2 29 2 5 22 9 1.33
K-MMSE: the Korean version of the Mini-Mental State Examination, H&Y stage: Hoehn and Yahr stage, UPDRS: Unified Parkinson’s Disease Rating Scale, BDI: Beck Depression Inventory, FSS: 
Fatigue Severity Scale.
Supplementary table 2. Dual task cost (%) used for the measurement of dual task effect
DTC in 7 patients (before treatment ) DTC in 4 patients (after treatment )
Pre-exercise at visit 1 Post-exercise at visit 2 p-value* Pre-exercise at visit 3 Post-exercise at visit 4 p-value
- 48.8 ± 47.0 2.9 ± 41.5 0.018 -25.7 ± 15.2 -8.8 ± 12.9 0.068
The values are means ± SDs. *p < 0.05 indicates a significant difference. DTC: dual task cost.
Supplementary Table 3. Effect of medication on the sequence ef-
fect
Sequence effect (4 patients)
p-value*
No medication (visit 1) Medication (visit 3)
Pre-exercise 17.9 ± 13.2 20.5 ± 12.9 1.000
The values are means ± SDs. *p < 0.05 indicates a significant differ-
ence. 
